Published by Coherent Market Insights
Posted on October 1, 2021
5 min readLast updated: February 1, 2026
The Automatic Cell Imaging System market is expanding due to rising cancer rates and technological advancements by key players like GE Healthcare.
Live cell imaging, or cell imaging is the examination of living cells using time-lapse microscopy (time-lapse photography applied to microscopy). Cell Imaging is used by scientists to get a better understanding of the biological functions of the body in the course of the study of cellular dynamics. The process was established in first half of the 20th century. The first time-lapse microcinematographic films showed the development and fertilization of a sea urchin egg. Various methods of microscopy have since been developed, thereby allowing researchers to experiment on living cells with greater detail and with less effort. A new kind of imaging, which uses quantum dots, has been pioneered as they are found to be more stable.
Request Sample Copy of This Report @
https://www.coherentmarketinsights.com/insight/request-sample/499
As the occurrence of cancer is rising at an alarming rate, so is the need for automatic cell imaging system. Automatic cell imaging system offers grass root level analysis of the division of cancer cells and hence researchers are using this technique to find a cure to the fatal disease. This is likely to fuel the growth of the overall automatic cell imaging system market.
Rising prevalence of cancer is expected to propel the automatic cell imaging system market over the forecast period. According to the World Cancer Research Fund International (WCRFI), in 2012, around 14.1 million cancer cases were estimated worldwide, in which, around 7.4 men and 6.6 million female were diagnosed. As per WCRFI, it is predicted that by 2035, world-wide around 24 million cancer cases will increase. The most common cancers were breast cancer, colon and rectum cancer, kidney and renal pelvis cancer, prostate cancer, non-Hodgkin lymphoma, leukemia, thyroid cancer, lung and bronchus cancer, melanoma of the skin, bladder cancer, pancreatic cancer, and endometrial cancer. The quantity of new cases of cancer was 454.8 per 100,000 women and men per year (statistic based on 2008-2012 cases). Additionally, the number of deaths due to cancer was 171.2 per 100,000 women and men per year (statistic based on 2008-2012 cases).
Rising product approvals and product launch by the market players is expected to propel the market growth. For instance, in February 2018, Molecular Devices, LLC, launched ImageXpress Pico Automated Cell Imaging System which automates the manual procedures such as acquisition steps and post processing of images and offers user efficient tool in research work
Major Players in Automatic Cell Imaging System Market
GE Healthcare Life Sciences, West Medica, Norma Diagnostika GmbH, Bioview, Caliber I.D., Molecular Devices, BioTek Instruments, and PerkinElmer., Inc.
Ask for PDF sample copy of the Automatic Cell Imaging System market report @
https://www.coherentmarketinsights.com/insight/request-pdf/499
Why this is Important Report to you? It helps:
• To analyze and study the Global Automatic Cell Imaging System Market capacity, production, value, consumption, status Focuses on the Key Automatic Cell Imaging System manufacturers, to study the capacity, production, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application, and region.
• To analyze the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
• To identify significant trends and factors driving or inhibiting market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the Automatic Cell Imaging System Market.
• To strategically profile the key players and comprehensively analyze their growth strategies.
• It provides a forward-looking perspective on different factors driving or restraining Market growth.
• It provides a six-year forecast assessed on the basis of how the Market is predicted to grow.
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors.
• It helps in making informed business decisions by having complete insights and by making an in-depth analysis of Market segment
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/499
In conclusion, the Automatic Cell Imaging System market report presents the descriptive analysis of the parent market supported elite players, present, past, and artistic movement information which is in a position to function as a profitable guide for all the Automatic Cell Imaging System industry business competitors. Our expert research analyst’s team has been trained to supply in-depth marketing research reports from every individual sector which can be helpful to know the industry data within the most precise way.
Contact:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Automatic Cell Imaging System Market Industry 2021 | GE Healthcare Life Sciences, West Medica, Norma Diagnostika GmbH appeared first on Gatorledger.
The article focuses on the Automatic Cell Imaging System market and its growth due to technological advancements and rising cancer rates.
How are quantum dots used in cell imaging? Quantum dots provide stable imaging, enhancing the detail and efficiency of cell imaging.
Who are the major players in this market? Key players include GE Healthcare, West Medica, and Molecular Devices.
Explore more articles in the Research Reports category
